amodiaquine has been researched along with Basal Ganglia Diseases in 4 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Russom, M | 1 |
Tesfai, D | 1 |
Gebregiorgis, S | 1 |
Usman, A | 1 |
Mihreteab, S | 1 |
Bahta, I | 1 |
Mekonnen, E | 1 |
Ghebrehiwet, S | 1 |
Abrham, G | 1 |
McEwen, J | 2 |
Bompart, F | 1 |
4 other studies available for amodiaquine and Basal Ganglia Diseases
Article | Year |
---|---|
Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment.
Topics: Adolescent; Adult; Age Factors; Amodiaquine; Antimalarials; Artemisinins; Basal Ganglia Diseases; Ch | 2016 |
Artesunate- and amodiaquine-associated extrapyramidal reactions: a series of 49 cases in VigiBaseā¢.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Africa; Amodiaquine; Antimalarials; Arte | 2012 |
Artesunate- and amodiaquine-associated extrapyramidal reactions: information gained from an African-based risk management plan.
Topics: Adverse Drug Reaction Reporting Systems; Amodiaquine; Antimalarials; Artemisinins; Basal Ganglia Dis | 2013 |
Author's reply to Bompart: "Artesunate- and amodiaquine-associated extrapyramidal reactions: information gained from an African-based risk management plan".
Topics: Adverse Drug Reaction Reporting Systems; Amodiaquine; Antimalarials; Artemisinins; Basal Ganglia Dis | 2013 |